BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9589048)

  • 41. DNA ploidy patterns in gallbladder adenocarcinoma.
    Yamamoto M; Oda N; Tahara E
    Jpn J Clin Oncol; 1990 Mar; 20(1):83-6. PubMed ID: 2319702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric DNA ploidy analysis of feline mammary tumors.
    Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
    Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of flow cytometric DNA analysis in patients with rectal cancer].
    Yamasaki S; Kumashiro R; Yoshitake H; Sano C; Maekawa T; Kido K; Tanaka K; Inutsuka S
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):775-9. PubMed ID: 8489285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [DNA ploidy pattern as an indicator of degree of malignancy and prognosis in gastric cancer].
    Kitamura M; Arai K; Miyashita K; Takahashi K; Kato H; Takamoto S; Maeda Y
    Nihon Rinsho; 1992 Oct; 50(10):2401-7. PubMed ID: 1447810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation between intratumor DNA ploidy distribution pattern and prognosis by tumor stage in colorectal carcinomas].
    Sasaki O; Nagahama S; Kusano T; Soejima K
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():107-11. PubMed ID: 8678551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
    Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
    Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
    Hara S; Tomita M
    Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Manotti L; Pilato FP; Mazzini G; Cocconi G
    Diagn Cytopathol; 1996 Aug; 15(2):116-20. PubMed ID: 8872432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
    Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
    Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
    Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection.
    Eliasen CA; Opitz LM; Vamvakas EC; Espiritu EC; Marsh ER; Roses DF; Harris MN; Feiner HD
    Mod Pathol; 1991 Mar; 4(2):196-200. PubMed ID: 2047382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of malignant potential on colorectal carcinoma utilizing expression of epidermal growth factor and DNA ploidy patterns].
    Yamada H; Kurooka K; Funai S; Fujii Y; Imanishi Y; Sato S; Watatani M; Shindo K; Yasutomi M
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():186-91. PubMed ID: 7611788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.